Frontlight ResearchEarly access
Trial site
IFO-Regina Elena Institute for Cancer Research
- 9running trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Lung cancer4 trials
- Colorectal cancer2 trials
- Melanoma1 trial
- Myelodysplastic syndromes1 trial
- Prostate cancer1 trial
- Phase
- Phase 27 trials
- Phase 31 trial
- Phase 41 trial
- Status
- Recruiting6 trials
- Active, not recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Fondazione Ricerca Traslazionale3 trials
- A.C.O.M. Advanced Center Oncology Macerata S.r.l.1 trial
- Associazione Qol-One1 trial
- ETOP IBCSG Partners Foundation1 trial
- European Organisation for Research and Treatment of Cancer - EORTC1 trial
- and 2 more
Running trials
Recruiting
Recruiting
Recruiting
Neoadjuvant chemo-immunotherapy for stage III PD-L1 positive Non-Small Cell Lung Cancer (NSCLC)
Recruiting
Recruiting
Active, not recruiting
Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status
Active, not recruiting
Not yet recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Lung cancer3 recruiting
- Colorectal cancer2 recruiting
- Myelodysplastic syndromes1 recruiting
- Prostate cancer1 recruiting
Site data: EU CTIS (euclinicaltrials.eu)Updated 18 Nov 2026